How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,325 results for

Diarrhea Secondary to Medications

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature (PubMed)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature BACKGROUND DRESS is a rare, life threatening syndrome that occurs following exposure to certain medications, most commonly antibiotics and antiepileptics. While sulfonamide antibiotics are frequently implicated as causative agents for DRESS syndrome, furosemide, a nonantibiotic sulfonamide, has not been routinely reported as the causative agent despite its (...) . CONCLUSIONS We report a case of severe DRESS syndrome secondary to furosemide, only the second case report in medical literature implicating furosemide. Given its widespread use, the potentially life-threatening nature of DRESS syndrome and the commonly delayed time course in establishing the diagnosis, it is important to remember that, albeit rare, furosemide can be a cause of DRESS syndrome.

Full Text available with Trip Pro

2018 The American journal of case reports

62. Modafinil for Sleep Disorders and Fatigue Secondary to Multiple Sclerosis: A Review of the Clinical Efficacy and Safety

Modafinil for Sleep Disorders and Fatigue Secondary to Multiple Sclerosis: A Review of the Clinical Efficacy and Safety Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable (...) efforts within the time allowed. Rapid responses should be considered along with other types of information and health care considerations. The information included in this response is not intended to replace professional medical advice, nor should it be construed as a recommendation for or against the use of a particular health technology. Readers are also cautioned that a lack of good quality evidence does not necessarily mean a lack of effectiveness particularly in the case of new and emerging

2012 Canadian Agency for Drugs and Technologies in Health - Rapid Review

63. Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea

of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: PTM202 PTM202 is a medical nutrition product Other: PTM202 Placebo Comparator: Placebo The placebo is a placebo for PTM202, a food product that can not be distinguished from PTM202 by appearance, taste or odor Other: Placebo Outcome Measures Go to Primary Outcome Measures : diarrhea duration [ Time Frame: 7 days ] Secondary Outcome Measures : food intake [ Time Frame: 7 days ] stool frequency [ Time Frame: 7 (...) Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study With Medical

2013 Clinical Trials

64. Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

allergy to Lanthanum Carbonate hypophosphatemia (defined as serum phosphorus < 0.81 mmol/L) severe known liver insufficiency of biliary obstruction rectocolitis ulcerohaemorraghica, Crohn's disease, bowel obstruction, stomach/duodenal ulceration glucose/galactose malabsorption severe diarrhea or other gastrointestinal disorder, which might interfere with the ability to absorb oral medication pregnancy or breast-feeding female participant of childbearing potential unwilling to take efficient (...) Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2017 Clinical Trials

65. Chronicles of a Second Year Medical Student

Chronicles of a Second Year Medical Student Chronicles of a Second Year Medical Student – Clinical Correlations Search Chronicles of a Second Year Medical Student August 6, 2015 5 min read By Matthew Siow Peer Reviewed Day 1 of the medicine rotation: complete. I was on long call today, which meant three things. One, the hours during which I had to pretend I knew something were longer. Two, I saw a lot of things I had never seen before, from more common things like COPD exacerbations and acute (...) of cake. I’ll do a couple questions tonight just to get my feet wet. You know what they say: a journey of 1,397 questions begins with a single step. Question 1 A 65-year-old male comes to your office to establish care. He tells you he has spent the last 40 years working as a shark tank tester in Botswana and once came within 100 feet of touching a shark. He believes this close encounter has led him to develop an allergy to shark fin soup. He takes no medications but admits taking “some kind

2015 Clinical Correlations

66. Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis (PubMed)

Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis Clostridium difficile infection (CDI) is the most common cause of health-care-associated infectious diarrhea. Recurrence rates are as high as 20-30% after standard treatment with metronidazole or vancomycin, and appear to be reduced for patients treated with fidaxomicin. According to the literature, the risk of CDI recurrence increases after the second relapse to 30-65%. Accurate data (...) for Germany are not yet available.Based on the research database of arvato health analytics (Munich, Germany), a secondary data analysis for the incidence, treatment characteristics and course of CDI was performed. The database included high granular accounting information of about 1.46 million medically insured patients covering the period 2006-2013, being representative for Germany. The analysis was based on new-onset CDI in 2012 in patients which either received outpatient antibiotic therapy for CDI

Full Text available with Trip Pro

2016 Infectious diseases and therapy

67. Syphilis: an atypical case of sepsis and multiple anogenital lesions in secondary syphilis (PubMed)

with severe septic shock and multiple anogenital lesions in an immunocompetent host. A 22-year-old male with no significant past medical history presented with fevers, chills, sore throat, diaphoresis, and diarrhea. He was febrile, tachycardic, hypotensive, and unresponsive to fluid resuscitation requiring short-term vasopressor support. Physical exam revealed diffuse lymphadenopathy; lower extremity macular rash involving the soles of the feet; papular non-pustular lesions on the scrotum; and a 0.5 cm (...) Syphilis: an atypical case of sepsis and multiple anogenital lesions in secondary syphilis The incidence of syphilis has historically been cyclical in nature, often in relation to the rise and fall of public health initiatives directed toward eradication along with social attitudes toward sexual practices. The incidence of syphilis has increased by 15% in the last 6 years in the United States, with similar increases worldwide. Herein, we present an atypical case of syphilis presenting

Full Text available with Trip Pro

2016 Journal of community hospital internal medicine perspectives

68. Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine

/DOQI Secondary Outcome Measures : Phosphocalcium product level [ Time Frame: 2 years ] Serum calcium level [ Time Frame: 2 years ] Serum phosphorus level [ Time Frame: 2 years ] Symptoms and / or clinical events caused by hyperparathyroidism [ Time Frame: 2 years ] using clinical and paraclinical examinations Tolerance of therapeutic interventions: nausea, vomiting, diarrhea, hypocalcemia [ Time Frame: 2 years ] using clinical and paraclinical examinations The quality of life [ Time Frame: 2 years (...) but dialysed in a unit outside Lorraine. Diagnosis of secondary hyperparathyroidism with higher parathormone or equal to 500 pg / ml placed before 1/4/2009. Patient who have received medical treatment with cinacalcet or by surgical parathyroidectomy for secondary hyperparathyroidism. Patient expressing opposition to the collection of information. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research

2016 Clinical Trials

69. Causes of variability in prevalence rates of communicable diseases among secondary school Students in Kisumu County, Kenya (PubMed)

in female (7.96%) than male students.This study has revealed that the prevalences of diarrhea, tuberculosis, pneumonia and other respiratory tract infections are lower among female secondary school students than males and that the prevalence of malaria is higher in males than females. Age of secondary school students is a significant vulnerability factor for malaria, diarrhea, tuberculosis and pneumonia, which were the important communicable diseases most prevalent among secondary school students (...) Causes of variability in prevalence rates of communicable diseases among secondary school Students in Kisumu County, Kenya To determine causes of variability in communicable disease prevalence rates among students in secondary schools to inform policy formulation in the public health sector.A representative cluster sample size for students was estimated using Fisher et al.'s formula while schools, sub-counties and education zones were clustered and sample size was calculated based

Full Text available with Trip Pro

2016 Zeitschrift Fur Gesundheitswissenschaften

70. Medical Management of Kidney Stones

. Hypocitraturia is a common risk factor for stone disease with an estimated prevalence of 20-60%. 81, 82 Urinary citrate excretion is determined by acid-base status; metabolic acidosis or dietary acid loads enhance renal citrate reabsorption, thereby reducing urinary excretion. A number of medical conditions such as renal tubular acidosis and chronic diarrhea, and some medications, such as carbonic anhydrase inhibitors, may promote hypocitraturia. 82 Acidosis can arise from a diet that is inordinately rich (...) Medical Management of Kidney Stones Kidney Stones: Medical Mangement Guideline - American Urological Association advertisement Toggle navigation About Us About the AUA Membership AUA Governance Industry Relations Education AUAUniversity Education Products & Resources Normal Histology and Important Histo-anatomic Structures Urinary Bladder Prostate Kidney Renovascular Diseases Andrenal Gland Testis Paratesticular Tumors Penis Retroperitoneum Cytology Online Learning For Medical Students Exams

2014 American Urological Association

71. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics

Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics 1 © American College of Medical Genetics and Genomics ACMG St And ArdS And GuidelineS PURPOSE This guideline is intended as an educational resource. It high- lights current practices and therapeutic approaches to the diagnosis and management of GSD I and its early and long- term complications. GENERAL BACKGROUND History In 1929, von Gierke described glycogen (...) storage disease type I (GSD I) after reviewing the autopsy reports of two children whose livers and kidneys contained excessive amounts of Submitted 12 August 2014; accepted 12 August 2014; advance online publication 6 November 2014. doi:10.1038/gim.2014.128 Genet Med 00 00 2014 Genetics in Medicine 10.1038/gim.2014.128 ACMG Standards and Guidelines 00 00 12August2014 12August2014 © American College of Medical Genetics and Genomics 6November2014 Purpose: Glycogen storage disease type I (GSD I

2014 American College of Medical Genetics and Genomics

72. Medical Treatment for Microscopic Colitis: A Community Hospital’s Experience (PubMed)

Medical Treatment for Microscopic Colitis: A Community Hospital’s Experience Lymphocytic colitis (LC) is a chronic disorder characterized by watery diarrhea. This study sought to evaluate if LC recurs after therapy, and the time frame in which this occurs. Secondary objectives included length and type of therapy, drug-free intervals, and reasons for drug discontinuation.A retrospective chart review between January 1, 2008 and October 30, 2015 of patients with biopsy-confirmed lymphocytic (...) , collagenous, or microscopic colitis was conducted. Patient-reported average bowel movements/day were reviewed. Demographic data, dates of colonoscopy, follow-up, type and dose of medications used, and therapy start/stop dates were reviewed.Patients presenting with colonoscopic documented LC (n = 114) were predominantly female (88%), Caucasian (97%), with mean bowel movements/day of five. A total of 58/114 (51%) patients were placed on a therapy. Patients taking budesonide saw bowel movements/day reduced

Full Text available with Trip Pro

2018 Gastroenterology research

73. Branched Chain Amino Acids Ratio in Medical Foods

Branched Chain Amino Acids Ratio in Medical Foods Branched Chain Amino Acids Ratio in Medical Foods - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Branched Chain Amino Acids Ratio in Medical Foods (...) by (Responsible Party): Rajavel Elango, PhD, University of British Columbia Study Details Study Description Go to Brief Summary: This study will evaluate the branched-chain amino acids (BCAA) ratio in the medical foods formulated for Methylmalonic and Propionic Acidemias (MMA/PROP) patients. We will recruit 6 healthy children between 6-10y (3 boys and 3 girls). They will be given amino acid-based shakes and protein free cookies. Using a minimally invasive stable isotope based technique, we will be able

2018 Clinical Trials

74. Bladder Antimuscarinic Medication and Accidental Bowel Leakage

: Severe constipation, fecal impaction or overflow fecal incontinence Inflammatory bowel disease, colorectal CA, spinal cord injury, multiple sclerosis, stroke, myasthenia gravis Infectious diarrhea Bothersome SUI (defined as "moderately" or greater bother on UDI-3) Patients planning to undergo surgery during study period Patients who are pregnant or intending to become pregnant during the study period Patients with contraindications to antimuscarinic medications (ie. closed angle glaucoma) Patients (...) Bladder Antimuscarinic Medication and Accidental Bowel Leakage Bladder Antimuscarinic Medication and Accidental Bowel Leakage - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Bladder Antimuscarinic

2018 Clinical Trials

75. Inulin-Type Fructan Supplementation of 3 to 6 Year-Old Children Is Associated with Higher Fecal Bifidobacterium Concentrations and Fewer Febrile Episodes Requiring Medical Attention. (PubMed)

Inulin-Type Fructan Supplementation of 3 to 6 Year-Old Children Is Associated with Higher Fecal Bifidobacterium Concentrations and Fewer Febrile Episodes Requiring Medical Attention. Inulin-type fructans used in formula have been shown to promote microbiota composition and stool consistency closer to those of breastfed infants and to have beneficial effects on fever occurrence, diarrhea, and incidence of infections requiring antibiotic treatment in infants.The primary study aim was to explore (...) whether prophylactic supplementation with prebiotic fructans is able to influence the frequency of infectious diseases in kindergarten children during a winter period. A secondary objective was to ascertain the effect on the intestinal microbiota.142 boys and 128 girls aged 3-6 y were randomly allocated to consume 6 g/d fructans or maltodextrin for 24 wk. At baseline, stool samples were collected for microbiota analysis and anthropometric measurements were made. During the intervention period

Full Text available with Trip Pro

2018 Journal of Nutrition Controlled trial quality: uncertain

76. Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02565654 Recruitment Status : Unknown Verified June 2015 by XiaojunZhuang, First Affiliated Hospital, Sun Yat-Sen University. Recruitment status was: Not yet recruiting First

2015 Clinical Trials

77. Probiotics in the Reduction of Antibiotic Associated Diarrhea

. Outcome Measures Go to Primary Outcome Measures : Antibiotic Associated Diarrhea [ Time Frame: 21 days after starting study treatment ] Subjects will be asked to keep a diary for 20 days after starting study treatment and will be contacted by a nurse approximately 21 days after starting study treatment Secondary Outcome Measures : Length of stay [ Time Frame: during hospitalization up to 4 weeks ] Mortality [ Time Frame: During hospitalization up to 4 weeks ] Healthcare costs [ Time Frame: During (...) coherency to understand consent Active Diarrhea at admission Non-controlled intestinal disease Documented positive C. difficile infection within the 3 months before enrollment Antibiotic use at hospital admission Immunosuppressive therapy Pregnancy Allergic to ingredients in Florajen-3 Allergic to ingredients in placebo Immunocompromised state including: HIV with a low CD4 count Active malignancy receiving chemotherapy Medications including long-term steroids (>2 weeks), and disease modifying biologic

2015 Clinical Trials

78. Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT

burden and nausea were barriers) First Posted : December 2, 2015 Results First Posted : June 14, 2017 Last Update Posted : June 14, 2017 Sponsor: Mayo Clinic Collaborator: Entera Health, Inc Information provided by (Responsible Party): Michael Camilleri, Mayo Clinic Study Details Study Description Go to Brief Summary: For patients who receive a hematopoietic cell transplant (HCT), there is a risk of developing a diarrhea secondary to the chemotherapy which we give. Diarrhea is usually harmless (...) the Bristol Stool Scale. The Bristol Stool Scale is a medical aid designed to classify the form of human feces into seven categories or types. Types 1 and 2 indicate constipation with 3 and 4 being the "ideal stools" especially the latter, as they are the easiest to defecate, and 5-7 tending towards diarrhea. Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends

2015 Clinical Trials

79. Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea

[ Time Frame: 5 days ] The primary efficacy criterion will be the frequency and consistency of diarrhea in hours, from the first treatment dose to recovery. It will be evaluated through stool D/R. Stool D/R described the consistency, frequency and other important features of stool. Semisolid stool consistency with 1-2/day will be considered significant. Secondary Outcome Measures : Improvement in clinical symptoms such as abdominal pain, abdominal distension, etc will be secondary outcome measures (...) Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Male or female adults between the age of 18-60 years who were suffering from diarrhea of presumed infectious origin and willing to participate were eligible for inclusion in the study. Exclusion Criteria: Exclusion criteria were the presence of chronic Iatrogenic, or bloody diarrhea, having received antibiotic treatment for other medical or surgical problems Having a history of renal or hepatic dysfunction Having

2015 Clinical Trials

80. Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir

days). ] The overall incidence of diarrhea, represented as a percentage of patients, that develop diarrhea during the course of their enrollment in the study (an average of 35 days). Secondary Outcome Measures : Incidence of Clostridium difficile infection among the three randomized study groups over time [ Time Frame: Assessed at any point during a patient's enrollment in the study (average of 35 days) when clinical symptoms require a C. difficile test per standard of care. Individual patients (...) Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>